Beckman Coulter Diagnostics, a clinical diagnostics leader, today introduces the new DxC 500i Clinical Analyzer*, an integrated clinical chemistry and immunoassay analyzer. As healthcare systems ...

Danaher (DHR) said today it has agreed to acquire Beckman Coulter (BEC) for $83. 50 per share, or a total value of $6.

Nearly two months after rumors swirled that Brea, California-based Beckman Coulter was looking at buyout offers, the company has agreed to be purchased in a deal valued at $6.8 billion. The ...

Beckman Coulter aims to expand its reach in accessible diagnostic tests for Alzheimer’s disease, to get ahead of potentially high demand as advancements are made in hopefully treating the ...

Beckman Coulter Life Sciences , a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation (NYSE: DHR), announces the appointment of Joe Fox as ...

In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal antibody-based Alzheimer’s disease therapeutics.

INDIANAPOLIS – (August 6, 2024) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array ...

Innovative superRCA technology from Rarity Bioscience AB enhances flow cytometry, expanding oncology research possibilities and improving mutation detection.

An office and industrial campus once occupied by biotechnology research company Beckman Coulter Diagnostics has hit the open market. Houston-based real estate company Hines hired Cushman & Wakefield ...

Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers.

INDIANAPOLIS – (April 30, 2024) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an ...

Beckman Coulter Diagnostics has announced a €10 million investment and 80 jobs. Pictured in its facility in Clare are Michael McGrath, former minister for finance and European Union Commissioner ...